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 Abstract 
Renal PEPT1 and PEPT2 cotransporters play an important role in the balance of circulating 
body oligopeptides and selected peptidomimetic drugs. We aim to comprehensively 
characterise age-related changes of the renal PEPT cotransporters at the gene, protein, and 
functional level. Brush border membrane vesicles (BBMV) and outer medulla membrane 
vesicles (OMMV) were isolated from the kidneys of young, middle-aged and old rats. The 
protein expression of PEPT1 was not only increased in BBMV from old rats, but PEPT1 also 
appeared in OMMV from middle-aged and old rats. SLC15A1 gene expression in the renal 
cortex increased in middle-aged group. PEPT2 protein expression was not only increased 
with ageing, but PEPT2 also was found in BBMV from middle-aged and old groups. 
SLC15A2 gene expression in the renal outer medulla increased in the old group. These 
changes in the expressions and localisations of PEPT1 and PEPT2 could explain the changes 
to transport activity in BBMV and OMMV. These findings provide novel insights that would 
be useful for maintaining protein nutrition and optimising the delivery of some 
peptidomimetic drugs in elderly individuals.             
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Introduction 
The percentage of people over 65 years of age was about 11% of the world population in 
2007. This percentage was predicted to progressively increase to 22%, of which one 
individual in every five would be 80 years old in 2050 [1]. Ageing is not a single condition 
but rather a representative term for the cumulative negative changes at the molecular, cellular 
and tissue level [2]. Multiple organs and systems, mainly the: kidney, liver, intestine, 
cardiovascular, and central nervous system undergo progressive functional impairments with 
ageing [3]. The effect of ageing on renal function and morphology has been extensively 
studied in different ways and in a wide range of subjects. Most of these studies reported 
major changes in kidney structure and concomitant decline in renal function [4-5]. For 
example, after the age of 40, nephron mass and renal blood flow start to decrease by 10% per 
decade and whilst the normal glomerular filtration rate (GFR) is 120 mL/min, it can decline 
to ~60-70 mL/min at age 85 [6]. However, the age-related decrease in GFR is still being 
debated, because of the coexistence of chronic kidney disease (CKD) in some elderly people 
[5]. Comorbidity of ageing and other diseases (e.g. diabetes and hypertension) occurs in most 
elderly individuals, which can affect the quality of life and can increase the risk of mortality 
[1].  
The initial portion of the nephron, namely the renal proximal tubule is the main site of 
reabsorption of almost all of the filtered organic compounds including amino acids. The 
percentage of small molecular weight peptides present in the circulating plasma is not clear 
yet, but it has been reported that approximately 50% of all amino acids circulate in the form 
of di-and-tripeptides [7]. The reabsorption of any filtered or enzymatically hydrolysed di-and-
tripeptides by PEPT1 and PEPT2 cotransporters in the proximal tubule of the kidney is a 
pivotal process in balancing protein intake according to the body needs. In addition to the 
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capability of PEPT1 and PEPT2 to transport approximately 8000 potential combinations of 
di-and- tripeptides, they are also able to translocate peptidomimetic drugs with clinical and 
pharmacological relevance. These include β-lactam antibiotics of the aminocephalosporin 
(e.g., Cefadroxil) and Penicillin (e.g., Ampicillin) classes; some antiviral (e.g., Valacyclovir); 
and anti-tumour drugs (e.g., δ-amino-levulinic acid and γ-glutamyl-L-cysteine); and selected 
angiotensin converting enzyme (ACE) inhibitors (e.g., captopril) [8-9]. 
Age-related changes in physiology can lead to compromised pharmacokinetics and 
pharmacodynamics including a reduction in renal and hepatic clearance and an increase in the 
volume of distribution of some drugs (e.g., ACE inhibitors). This can result in prolongation 
of drug half-life, which could be toxic to the system (reviewed in [1-2]). It has been 
emphasised that drug dosage must be appropriately adjusted in individuals with renal 
dysfunction to avoid further complication and adverse reactions [4, 10]. Therefore, the age-
dependent decline in renal function could have significant implications, not only on 
physiological homeostasis, but also on therapy and drug handling [4].  
Given that PEPT1 and PEPT2 cotransporters have been implicated in the transport of 
a wide range of di- and tripeptides besides many important peptidomimetic drugs, our 
hypothesis is that ageing affect these transporters at the molecular and functional level. This 
study provides the first experimental evidence for the effect of ageing on PEPT1 and PEPT2 
cotransporters in the kidney by comprehensively investigating the changes of localisation, 
gene and protein expression as well as corresponding protein function.     
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Material and Methods 
Ethical Approval 
This study was approved by the Animal Ethics committee of the University of New England, 
and complies with the Guide for the care and use of laboratory Animals published by the US 
National Institute of Health (NIH Publication No. 85-23, revised 1996). 
 
Chemicals 
All chemicals used in this study were of analytical quality. β-Ala-Lys (AMCA) was from Bio 
Trend Chemicals (Destin, USA). The antibodies: PEPT1, PEPT2, and β-Actin were from 
SANTA CRUZ. Primers were purchased from GeneWorks and Sigma. TSA amplification kit 
was from PerkinElmer. Sudan Black B was from Sigma. 
 
Kidneys of Animal Models 
The age categories of the male Wistar rat groups were chosen according to the criteria 
described previously by Sengupta [11]: young adult group (6-7 months), middle-aged group 
(17-18 months) and old group (23-24 months). Kidneys were removed from these groups 
after stunning and cervical dislocation. The kidneys were snap frozen in liquid nitrogen prior 
to transfer to -80 °C until used for the experiments. Some of these snap-frozen kidneys were 
transferred to the Charles Perkins Centre at the University of Sydney for conducting part of 
the immunohistofluorescence studies.  
 
 
6 
 
Isolation of Brush Border Membrane (BBMV) and Outer Medulla Membrane (OMMV) 
Vesicles and their quality assessment 
BBMV were prepared from 1-2 mm thick slices of superficial cortex from the kidneys of 
Wistar rat groups, while OMMV were sliced from pieces of the outer medulla, which are 
characterised by red stripes on visual inspection of the tissue samples [12]. The BBMV and 
OMMV were prepared by dual-stage Mg++ precipitation in the presence of EGTA as 
described previously [13]. After isolation, vesicles were suspended with intra-vesicular 
medium containing in mM: 100 mannitol, 100 KH2PO4 and 10 HEPES (pH 7.4 with TRIS) 
and centrifuged at 31,000 ×g for 20 min at 4 °C. The resulting pellets were re-suspended in 
the same buffer (500 μL) and pre-equilibrated using the freeze-thaw fractionation method 
[14]. The quality of the isolated BBMV and OMMV was verified by measuring the enzyme 
activities and enrichments of leucine aminopeptidase (LA) and alkaline phosphatase (AP) 
[13]. The enrichments of LA and AP in all preparations were higher than 10-fold (see table 1 
in supplementary file). These values are comparable with previous studies and indicate that 
the procedure yielded high-quality and uncontaminated vesicles [13, 15]. The protein 
concentration of each vesicular isolate was quantified using Bradford’s method as described 
previously [16].  
Several measures were undertaken to minimise adventitial oxidation in these 
preaprations. While dissecting the kidneys, renal slices were transferred to ice-cold buffer 
containing (in mM): 300 Mannitol, 5 Ethylen glycol tetraacetic acid (EGTA), and 10 2-[4-(2-
hydroxymethyl)-aminomethan (TRIS)). Both EGTA and mannitol are antioxidants; EGTA 
binds various divalent cations (including Fe and Cu) to render these metals redox inactive 
[17], and mannitol can scavenge potent one-electron oxidants such as hydroxyl radical [18]. 
BBMV and OMMV isolated by the method of Biber et al. [13] illustrated are devoid of 
contamination by mitochondria and endoplasmic reticulumindicating that these vesicles lack 
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intracellular machinery components that promote ROS generation.  Finally, after isolation all 
vesicles were immediately snap frozen in liquid nitrogen prior to storage at  -80C until use 
(within 4 weeks of isolation). 
 
Fluorescence measurements in BBMV and OMMV  
The transport activity of PEPT1 and PEPT2 in BBMV and OMMV were measured using the 
fluorophore-conjugated dipeptide β-Ala-Lys (AMCA) as we described previously [19]. 
Briefly, β-Ala-Lys (AMCA) was prepared to its maximum soluble concentration (2.32 mM 
according to BioTrend) in the extra-vesicular buffer containing in mM: 100 KH2PO4, 100 
mannitol, and 10 2-(N-Morpholino) ethanesulfonic acid (MES)- 
tris(hydroxymethyl)aminomethane (TRIS) (pH 6.6). Vesicles containing 45 μg of total 
proteins (~15 μL) were added to 7 different concentrations of β-Ala-Lys-AMCA (ranging 
from 5 to 2000 μM) with extra-vesicular buffer added to yield a final reaction volume of 250 
µL into Eppendorf tubes. After incubation for 20 min at 20 °C, the transport of the substrate 
was stopped by transferring the mixture into centrifuge tubes containing 5 mL of ice-cold 
extra-vesicular buffer prior to spinning at 31,000×g for 20 min at 4 °C. The resulting pellets 
were washed 3 times with the extra-vesicular buffer (3 mL) and then resuspended in 500 μL 
of the same buffer. Reaction mixtures were then transferred into 96-well black microplates 
using 166 μL in each well arranged in triplicates. Fluorescence emission was measured at 455 
nm at an excitation wavelength of 350 nm using a microplate reader (SpectraMax-M2e). Each 
plate contained vesicles isolated from the three designated age groups so that all 
measurements were matched and taken under the same experimental conditions. 
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Immunofluorescence study 
Snap-frozen kidney samples embedded in Optimal Cutting Temperature Compound (OCT) 
were cut into 7 micron sections using a cryostat (Leica CM 1850) maintained at -18 °C. 
Three sections from three different groups (young, middle-aged, and old) were mounted onto 
Superfrost Plus slide (Thermo Scientific) and air-dried for 30 min at 22 °C. A control was 
prepared for each specimen on a separate Superfrost Plus slide. The slides were then wrapped 
with aluminium foil prior to transferring to a -80 °C freezer for later use. In this way, the 
tissue architecture was partially protected from moisture damage when taking them out again 
for staining. Kidney tissues are known to produce high autofluorescence (AF), which can be 
an obstacle in detecting specific antibody-labelled immunofluorescence probe. Sun et al. [20] 
showed that 0.1 % (w/v) of Sudan Black B (SBB) was effective in blocking intense AF 
arising from the kidney tissues of normal and nephropathy mice without adversely interfering 
with the specific immunofluorescence signal in frozen sections. In this study, it was found 
that AF was high especially in the kidney tissues of middle-aged and old rats; hence it was 
required to optimise for the best percentage of SBB (ranging from 0.1 to 0.5% w/v), of which 
0.3% w/v was ascertained to be effective in blocking AF (see Figure 1 in supplementary file). 
In addition, Tyramide Signal Amplification (TSA) Systems (PerkinElmer), which is an 
enzyme-mediated detection utilising HRP to generate high-density labelling with sensitivity 
up to 100-fold higher than conventional method, was used in this experiment as the affinity of 
the fluorescently labelled antibodies was affected. By this method, it was also possible to 
probe the tissues with the same antibodies used in Western blotting.                
Where required, the foil-wrapped slides were taken out of the freezer and equilibrated 
at 22 °C for 30 min prior to fixing in ice-cold acetone for 20 min. After that, they were gently 
washed with water and incubated with 0.3% v/v H2O2 for 15 min to quench endogenous 
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peroxidase activity. The slides were washed 3 times with TBS-T buffer containing in mM: 
150 NaCl, 20 Tris-HCl (pH 7.5) and 0.1% Tween 20, followed by 1 h incubation with either 
1:400 (v/v) mouse monoclonal anti-PEPT1 or goat polyclonal anti-PEPT2 for 1 h at RT. This 
was followed by 3 times washing with TBS-T and incubation with secondary antibodies goat/ 
antimouse or mouse/ antigoat accordingly in 1:300 (v/v) dilution. After removing the 
secondary antibodies by washing 3 times with TBS-T, 1:50 (v/v) TSA-CY 3.5 was added to 
the slides for 10 min, followed by washing 3 times with TBS-T prior to applying SBB (0.3% 
w/v in 70 % v/v ethanol/H2O) for 30 min. Finally, the sections were washed with TBS-T for 
10 min and then mounted with Dako cytomation fluorescent mounting medium containing 
DAPI (Dako, USA) and placed under a coverslip. Control slides containing the same sections 
were used to confirm the suppression of AF in SBB-treated sections, and to examine the 
specificity of the staining by probing the sections with only secondary antibodies (no primary 
antibody). A TI eclipse (Nikon corporation, Tokyo, Japan) equipped with a colour cooled 
DXM1200C digital camera was used for fluorescence imaging. The optimum conditions of 
gain and exposure time were established in a preliminary experiment based on the AF level 
of untreated and SBB-treated sections of all age groups. Exposure time was set to 300 ms and 
the gain was set to 6.3. Images of resolution 1280×1024 px were acquired for the blue, green, 
red channels and a brightfield.  
 
Western blotting 
BBMV and OMMV isolated from the kidneys of each age group were used to probe for 
PEPT1 and PEPT2 proteins using Western blotting as described previously [21]. Briefly, 35 
or 45 µg proteins of these vesicle preparations were separated on a SDS-PAGE Mini-Protean 
Gels (4-20%, Bio-Rad) and transferred on a nitrocellulose membrane. After blocking the 
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membranes overnight with 5% w/v skim milk dissolved in TBS-T buffer, they were probed 
with either mouse monoclonal anti-PEPT1 or goat polyclonal anti-PEPT2. This was followed 
by probing with Horse radish peroxidase-conjugated goat anti-mouse and mouse anti-goat. 
Following the probing stages by primary and secondary antibodies and after incubation with 
the secondary antibodies, the membranes were washed three times for 10 min with TBS-T 
buffer. After that, ECLTM Western Blotting Analysis System (GE Healthcare) was used 
according to the manufacturer’s instructions to image the protein bands on HyperfilmTM ECL 
films (GE Healthcare). The same membranes were then stripped and re-probed with mouse 
monoclonal anti-β-Actin. The intensity of protein bands were quantified using BIO-RAD 
GEL DOC EQ system and its associated software (Quantity One. inc).   
 
 RT-PCR and real-time RT-qPCR 
Biopsies of renal tissues (18 mg) were removed from the superficial cortex and outer medulla 
of renal tissue for each age group (samples were taken from kidneys previously snap-frozen 
for storage). Total RNA was isolated from these tissues using ISOLATE II RNA Mini Kit 
(BIOLINE, Cat No: Bio-52072). Three quality control experiments were performed prior to 
proceeding to cDNA synthesis: (1) the RNA purity and quantity was checked by measuring 
the absorbance at 260/280 ratio >1.9 with a NanoDrop UV-Vis Spectrophotometer (Thermo 
Scientific); (2) the RNA integrity was confirmed by 1% w/v agarose gel where the intensity 
of tRNA 28S was twice that of the 18S bands; (3) possible contamination by genomic DNA 
was checked by adding 10 ng of RNA from each sample to 0.5 μM forward and reverse 
PEPT primers, 5 μL SYBR green, and 3 μL nuclease-free water. These experiments, which 
were run under the same conditions as described below for the cDNA samples did not show 
any amplification, indicating good RNA isolation (see Figure 2 in supplementary file). 
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cDNA synthesis of isolated total RNA samples was performed in 96-well plates (T 
100TM Thermal Cycler, Bio-Rad) using Tetro cDNA Synthesis Kit (BIOLINE). Total RNA (5 
μg) was mixed with Oligo (dT)18, Random Hexamer, dNTP mix, RiboSafe RNase Inhibitor, 
and Tetro Reverse Transcriptase according to the manufacture instructions. The resulting 
cDNA was then used to perform q-PCR, by mixing 5 μL SensiFASTTM SYBR (Bioline) with 
cDNA (10 ng RNA; the use of RNA concentration as the concentration for cDNA is 
recommended and since the isolated RNA was diluted in RNAse free water, it was possible to 
blank against this water using a nanodrop spectrophotometer) and 500 nM forward and 
reverse primers (Table 1) in a 384-well plate (in duplicate). Primers for β-Actin, and SDHA 
(succinate dehydrogenase) were found to be the most stable internal reference genes in rat 
kidneys with ageing, but not TBP (TATA Box binding Protein) nor GAPDH (glyceraldehyde 
3-phosphate dehydrogenase) in this experiment. The loaded 384-well plate was read on a 
QRT-PCR Bio-Rad CFX plate reader. This was started by denaturation at 95 °C for 2 min, 
followed by amplification for 39 cycles of denaturation, annealing and extension as follows: 
95°C/10s, 60°C/20s, 72°C/15s. These reactions were always followed by 1 cycle step to 
generate the melt curve at 95°C/0.5s, 65°C/0.5s, 95°C/5s. The ΔΔ Cq method of the Bio-Rad 
CFX Manager 3.1 was used to determine differences between samples by normalising with 
two reference genes. All samples produced single peaks, indicating specific product 
amplification. The predicted sizes of products were examined by running samples (5 μL) on 
2% agarose gel, which showed the expected sizes. Before these steps, two samples were only 
converted to cDNA to check the specificity of the primers. The MIQE guidelines for the 
minimum information of RT-qPCR experiments were followed in this study [22]. 
 
Statistical Analysis 
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Data from transport experiments and relative measurements of protein and gene level were 
expressed as means ± SE of n experiments. Students T test or one-way ANOVA as 
appropriate were used to test for significant differences. A p value < 0.05 was considered 
significant. 
 
Results 
Kinetic measurements of β-Ala-Lys (AMCA) uptake  
The fluorescence intensity changes following incubation with β-Ala-Lys (AMCA) for the 
BBMV and OMMV obtained from kidneys isolated from the different age groups (young 
adult, middle-aged and old rats) were plotted versus increasing β-Ala-Lys (AMCA) 
concentration. The points were then curve fitted using the Michaelis-Menten equation. The 
Michaelis-Menten curves for β-Ala-Lys (AMCA) uptake into BBMV and OMMV isolated 
from the kidneys of all rat groups are shown with corresponding curve-fits (Figure 1 and 2; 
R2>0.9). An effect of ageing on β-Ala-Lys (AMCA) transport by BBMV and OMMV was 
clearly seen when comparing the transport kinetic parameters Km and Vmax (Table 2). In the 
young group, OMMV showed significantly higher affinity than BBMV (P=0.0004), but 
significantly lower capacity than BBMV (P=0.0003). By contrast, middle-aged and old 
groups did not show any significant differences in the affinity or capacity between BBMV 
and OMMV. The affinity of β-Ala-Lys (AMCA) uptake by BBMV in middle-aged and old 
groups was significantly higher than BBMV in young adult group (both P=0.001), however 
the capacity was significantly lower than BBMV in young adult group (both P=0.0001). In 
addition, the affinity of OMMV to β-Ala-Lys (AMCA) in middle-aged was significantly 
higher than OMMV in young adult group (P=0.01), but the capacity was significantly lower 
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than OMMV in young adult group (P=0.005). No significant differences in affinity or in 
capacity was determined between middle-aged and old groups (Table 2). 
 
Localisation of PEPT1 and PEPT2 in the rat kidney with ageing 
The normal distribution of PEPT1 and PEPT2 cotransporters along the proximal tubule was 
reported previously to be exclusively situated in Segments 1 and 3 respectively [12, 23]. As 
shown in Figure 3 (A, G), PEPT1 is present in the superficial cortex region of young kidneys, 
but not in deeper segments as opposed to the middle-aged and old rats which revealed a 
progressively wider spread of PEPT1 distribution (3B-C, H-I) in all segments of the proximal 
tubule and medulla. Similarly, red-PEPT2 specific staining was most intense in the outer 
medulla of the young group with progressively weaker staining in the cortex and medulla 
(4A, G), as opposed to middle-aged and old groups that showed a more consistent positive 
staining intensity in the cortex and medulla (Figure 4 B-C, H-I). Notably, both transporters 
seem to be present in the kidney glomeruli of middle-aged and old groups as judged by 
immune-positivity in these kidney regions.  
 
Protein expression of PEPT1 and PEPT2 in kidney membrane vesicles 
Western blot assay was used in this experiment to relatively quantify the presence of PEPT 
cotransporters in two main regions of the renal proximal tubule of different age groups of 
Wistar rats. As shown in Figures 5 and 6, both BBMV and OMMV were probed with anti-
PEPT1 and anti-PEPT2 antibodies. The bands intensities of these proteins together with their 
corresponding β-actin bands were quantified and the results were summarised in Figure 7. 
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These data indicated that there were significant differences in PEPT1 and PEPT2 
protein levels in all age groups (ANOVA, P = 0.03 and 7x10-8 respectively). The presence of 
PEPT1 in OMMV and PEPT2 in BBMV (i.e., regions where these proteins are reported to be 
absent) from old and middle-aged groups was also confirmed in these experiments and 
verifies the immuno-histochemical data above. This was followed by post-hoc t-test which 
indicated a significant increase in the intensity ratio of PEPT1 protein in BBMV of old group 
(Figure 7A): PEPT1 in young BBMV vs. PEPT1 in old BBMV (P=0.04); PEPT1 in middle-
aged BBMV vs. PEPT1 in old BBMV (P=0.01); PEPT1 in middle-aged BBMV vs. PEPT1 in 
middle-aged and old OMMV (P=0.03). However, no significant differences were seen 
between young BBMV vs. middle-aged BBMV and OMMV. Further, the intensity ratios of 
PEPT2 protein in OMMV and BBMV showed significant changes (Figure 7B): PEPT2 in 
young OMMV vs. PEPT2 in middle-aged OMMV and BBMV (P=0.001, and 4x10-5), and vs. 
PEPT2 in old OMMV and BBMV (P= 2x10-5 and 5x10-5 respectively). Also, PEPT2 in 
middle-aged OMMV vs. PEPT2 in middle-aged BBMV (P=0.001) and vs. PEPT2 in old 
OMMV and BBMV (P=0.005, and 0.001 respectively).  
 
RNA expression of PEPT1 and PEPT2 with ageing 
The expression of SLC15A1 and SLC15A2 genes encoding PEPT1 and PEPT2 transporters 
respectively, in the superficial cortex and outer medulla of the renal proximal tubules were 
then determined with quantitative PCR. The relative normalised values extracted from Bio-
Rad CFX Manager 3.1 were examined by Kolmogorov-Smirnov to test for the non-normality 
distribution hypothesis. This test showed that these values were normally distributed, hence 
the analysis approach using ANOVA followed by post-hoc t-test was applied to investigate 
the differences between groups was validated. As shown in Figure 8, the relative expression 
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of SLC15A1 gene in the middle-aged group was significantly upregulated when compared to 
the young adult group (P= 0.04). However, the old group did not show any significant 
changes when compared to middle-aged or young adult groups. In addition, the relative 
expression of SLC15A2 gene in the old age group was significantly higher than both the 
young adult group and middle-aged group (P= 0.02 and 0.04 respectively), but no significant 
changes were found between the young adult and middle-aged groups. Furthermore, the 
relative gene expression of SLC15A2 were significantly higher than SLC15A1 in all ages: 
young adult (P= 0.04), middle-aged (P=0.005), and old group (P=0.0007). 
 
Discussion 
The major findings of this investigation were that the Km and Vmax of -Ala-Lys (AMCA) 
transport into BBMV and OMMV isolated from rat kidneys differed between young, middle-
aged and old rats (Fig. 1-2 and table 2). These changes could possibly be explained by a re-
distribution of the PEPT transporters in the kidney with ageing. This was demonstrated by the 
appearance of PEPT1 protein in the outer medulla and medulla of middle-aged and old rat 
kidneys (Fig. 3, 6-7), whilst PEPT2 protein was expressed in the cortex of middle-aged and 
old rat kidneys (Fig. 4, 6-7). In addition, the SLC15A2 (PEPT2) gene showed a significant 
increase in the old group compared to young and middle-aged groups (Fig. 8).  
One of the main results of this study was the redistribution of the renal PEPT 
transporters with ageing (Fig. 3-4, 6-7). The underlying mechanism could involve a 
compensatory process, which balances the loss of nephron mass and decreased glomerular 
filtration rate that is known to occur with ageing [5, 24]. Supporting evidence that PEPT 
transporters can be re-distributed in the kidney was obtained by Tramonti et al [25]. They 
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showed that following uninephrectomy PEPT1 and PEPT2 were expressed in all segments of 
the proximal tubule. 
The kinetic experiments described in our manuscript represent the uptake of -Ala-
Lys (AMCA) into BBMV and OMMV isolated from the kidneys of different aged rats. In 
BBMV from young rats there is only a single transporter present, PEPT1. In OMMV from 
young rats there is only PEPT2. However in the BBMV and OMMV isolated from the 
kidneys of middle-aged and old rats both PEPT1 and PEPT2 are present. This explains the 
changes in capacity and affinity of -Ala-Lys (AMCA) uptake in the two vesicle groups 
(table 2).   
The relationship between the intestinal PEPT transporters and ageing has been subject 
to limited investigation before. Knock-out of the pep2 (equivalent of PEPT1) gene in 
Caenorhabditis elegans did not have any effect on the lifespan [26]. Also with regard to 
intestinal PEPT transporters it has been shown that -Klotho causes down-regulation, which 
it was speculated could have an impact on ageing [27]. It should be noted, however, that 
unlike the current study neither of these studies directly investigated the effect of ageing on 
PEPT transporter expression and function in the kidney.  
Considering the nutritional and clinical implications of PEPT1 and PEPT2 
transporters, these results suggest that ageing may affect the renal handling of the hydrolysed 
proteins and peptide-like drugs including β-lactam antibiotics and some ACE inhibitors (used 
as anti-hypertensive agents). This could for example, make the management of hypertension 
in elderly patients more complicated than in the young as dose adjustment of hypertensive 
agents maybe required to avoid adverse effects [28-30]. 
Age-related changes in renal structure and function are often accompanied by one or 
more pathological conditions (e.g. hypertension, diabetes), which could lead to the instability 
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of individual homeostasis affecting renal handling of nutrients and drugs [4]. The 5/6 
nephrectomised rat has been widely used as an experimental model for the progression of 
renal damage and chronic renal failure which resemble the effect of ageing on the kidney 
based on the following:  (i) reduction of nephron mass, (ii) decreased glomerular filtration, 
(iii) presence of proteinuria, (iv) functional hypertrophy, and (v) morphological changes to 
the glomerulus [5, 24]. A study conducted by Takahashi et al. [31] showed that the protein 
and gene expression of PEPT2 significantly increased in the 5/6 nephrectomised rats, 
resulting in a 3-fold increase in Vmax, but without any changes in Km values as determined by 
functional activity studies. These findings are in agreement with this study of the age-related 
changes of PEPT cotransporters at the gene and protein expression levels. 
In addition to compensating for nephron loss and decreased glomerular filtration rate 
the change in PEPT transporters with ageing could also compensate for a changing hormonal 
and oxidant environment. It has been shown that leptin [32-33], growth hormone [35] and 
insulin [29, 36] stimulate the expression and activity of PEPT1. While the transport activity 
and expression of PEPT1 significantly decreased in Caco-2 cells challenged by the oxidant 
H2O2 [35], Caco-2 cells pre-treated with the thyroid hormone 3,5,3’-L-triiodothyronine (T3) 
[37], and hyperthyroid rats [38] demonstrated significantly higher gene and protein 
expression of the renal PEPT2 compared to the control rats [39]. With ageing comes leptin 
resistance [40] and increased insulin resistance coupled with glucose intolerance (reviewed in 
[41]), and decreased level of thyroid stimulating hormone (TSH) and T3 in the serum of 
elderly individuals (reviewed in [42]), which could play a role in the regulation of PEPT1 and 
PEPT2 cotransporters.  
Notably, ageing is not a single condition, but rather a term representative of 
cumulative changes at molecular, cellular, and tissue level [2]. The concept of progressive 
damage caused by age-dependent increases in ROS generation is one of the established 
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theories to explain why ageing occurs [6].  Thus, unregulated generation of ROS is associated 
with the pathogenesis of different chronic diseases such as atherosclerosis, hypertension, 
adiposity, cancer, and type II diabetes [43]. The age-related alterations on the PEPT1 and 
PEPT2 cotransporters identified here have the potential to impact renal metabolism of di-
tripeptides. Some amino acids, both in the form of single amino acids [44-45] or di-
tripeptides [46-48] play an important role as ROS scavengers such as singlet oxygen and •OH 
radicals, lipid peroxyl radicals, that further exacerbate ROS-mediated damage in ageing 
tissues. The scope of this present study was to investigate the effect of ageing on these 
cotransporters at the molecular level and we demonstrate that ageing has significant bearing 
on the expression level and renal distribution of these cotransporters. Confirming that other 
pathologies also impacted by altered renal cotransporter levels and tissue distribution is a 
relevant question that warrants further work in order to define their implications for PEPT 
cotransporters in different disease states. 
In conclusion, these findings and discussions may provide useful insights for the 
maintenance of nutritional amino acids and dosage optimisation of peptide-like drugs in the 
elderly and could help understanding of the underlying mechanism(s) regulating PEPT 
cotransporters and the relative change in co-transporter function in subjects from different 
age groups. 
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Figure Legends  
Fig. 1 Fluorescence changes as a function of β-Ala-Lys (AMCA) concentration following 20 
min incubation of BBMV (containing 45 μg protein) isolated from the kidneys of young adult 
(dotted line), middle-aged (solid line), and old (dashed line) rat groups (at pH 6.6). The 
curves are fitted to the Michaelis-Menten equation showing R2 >0.9. Data shown are means ± 
SE, n= 6 (in triplicate). 
Fig. 2 Fluorescence changes as a function of β-Ala-Lys (AMCA) concentration following 20 
min incubation of OMMV (containing 45 μg protein) isolated from the kidneys of young 
adult (dotted line), middle-aged (solid line), and old (dashed line) rat groups (at pH 6.6). The 
curves are fitted to the Michaelis-Menten equation showing R2 >0.9. Data shown are means ± 
SE, n= 6 (in triplicate) 
Fig. 3 Microscopy images of kidney cross sections. PEPT1 staining was measured using the 
immunofluorescent indicator TSA-CY 3.5 and is indicated in red. Images A, B and C 
represent young, middle-aged and old rat kidneys respectively. Images G, H, and I represent 
the outer medulla and medulla of young, middle-aged and old rat kidneys respectively. In 
these images the red staining has been merged with blue DAPI staining for DNA. Brightfield 
images were also acquired for the same sections (D-F and J-L). Magnification: 40X; 
resolution: 300 pixels/inch. Data shown are taken from a single experiment representative of 
4 such experiments.    
Fig. 4 Microscopy images of kidney cross-sections. PEPT2 staining was measured using the 
immunofluorescent indicator TSA-CY 3.5 and is indicated in red. Image A cortex and outer 
medulla of young rat kidneys. Images B and C outer medulla and medulla of middle-aged and 
old rat kidneys, respectively. Images G, H and I superficial cortex of young, middle-aged and 
old rat kidneys respectively. DAPI staining DNA (blue) was merged with the specifc-PEPT2 
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staining. Brightfield images were also acquired for the same sections (D-F and J-L). 
Magnification: 40X; resolution: 300 pixels/inch. Data shown are taken from a single 
experiment representative of 4 such experiments. 
Fig 5 Representative Western blotting bands for PEPT1 and PEPT2 proteins with their 
corresponding β-actin protein bands. (A) Investigations of the presence/absence of PEPT1 in 
BBMV isolated from young, middle-aged and old rat kidneys. (B) Investigations of the 
presence/absence of PEPT2 in OMMV isolated from young, middle-aged and old rat kidneys.  
Fig 6 Western blotting bands for PEPT1 and PEPT2 proteins with their corresponding β-actin 
protein bands. (A) Investigations of the presence/absence of PEPT1 and PEPT2 in BBMV 
and OMMV isolated from young rat kidneys. (B) Investigations of the presence of PEPT1 
and PEPT2 in BBMV and OMMV isolated from middle-aged and old rat kidneys. 
Fig 7 (A) Immunoblot analysis of PEPT1 and (B) PEPT2 proteins in BBMV and OMMV 
isolated from the kidneys of young, middle-aged and old Wistar rats. The protein 
concentration loaded in each lane of the gel was constant 45, or 35µg, each of which had its 
own control (β-actin). The relative protein abundance was calculated using autoradiographs, 
which were subjected to Bio-Rad scanning densitometry. This is followed by calculating the 
ratio of protein abundance for PEPT to β-actin (as PEPT1/ β-actin ×100). *P< 0.01 vs. all 
other groups, **P< 0.05 vs. middle-aged BBMV or OMMV, and vs. old BBMV and OMMV; 
and #P<0.05 vs. old BBMV. Data shown are means ± SE, n=6-9 
Fig 8 Relative normalised expression of PEPT1 and PEPT2 genes (against two reference 
genes SDHA, and β-Actin) measured by QRT-PCR and ΔΔ Cq method using Bio-Rad CFX 
manager 3.1. These genes are relatively quantified in the Cortex (Cox) and Outer medulla 
(OM) respectively for young adult, middle-aged, and old kidneys of Wistar rat, as colours 
shown in the graph. *P<0.05 vs. young cortex, **P<0.05 vs. young and middle-aged outer 
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medulla, and #P<0.05 vs. PEPT1. Data shown are means ± SE, n=5 (all samples were run in 
one 384 well plate and in duplicate) 
 
Table 1: Detailed information of all genes used in this study.  
 
Table 2: Kinetic parameters Km (μM) and Vmax (F/min/mg) for the uptake of β-Ala-Lys 
(AMCA) in BBMV and OMMV isolated from the Kidneys of all Wistar rat group. 
